Patrick J. Getty

Emerging drugs for high-grade osteosarcoma

Osteosarcoma treatment – Where do we stand? A state of the art review

Macrophages as regulators of tumour immunity and immunotherapy

The TAM family: phosphatidylserine-sensing receptor tyrosine kinases gone awry in cancer

Intratumoral activation of the necroptotic pathway components RIPK1 and RIPK3 potentiates antitumor immunity

TAM receptor tyrosine kinases as emerging targets of innate immune checkpoint blockade for cancer therapy

Specific Tyrosine Kinase Inhibitors Regulate Human Osteosarcoma Cells In vitro

Multiple receptor tyrosine kinases promote the in vitro phenotype of metastatic human osteosarcoma cell lines